来源：科技日报 数智化技术正为中医药产业带来前所未有的变革，古老的中医药智慧在数字时代焕发新的生机。8月24 日至25日，在甘肃省定西市陇西县举行的第六届中国（甘肃）中医药产业博览会期间，举办了数智化赋 能中医药产业高质量发展论坛。此次论坛汇聚人工智能（AI）、大数据领域的相关专家，共话数智化 赋能中医药产业高质量发展的新路径。 "新兴的智能中医诊疗技术可基于智能传感技术、大数据和知识图谱，融合经典医籍和名医经验，进行 中医'望闻问切'的四诊合参、辨证论治，实现中医处方和中医适宜技术的智能推荐。"天津大学生物医 学工程系副主任周鹏介绍，目前，该技术已在临床、科研、名老中医传承及大健康等领域中广泛运用。 除此之外，中医药行业也掀起了一股AI技术热潮。天士力数智中医药科技有限公司医学总监马奔欢坦 言，AI正快速成为药物研发重要的革新力量和热门领域，传统中药正逐步迈向"数智中药"，未来竞争将 愈发激烈。同时，利用数智技术加快中药新药研发，将推动中药复方的现代化研究，明确其作用机制和 活性成分。南京柯基数据科技有限公司CEO吴刚也表示，"知识图谱+大模型"成为双轮驱动的中医药产 业数智化转型新范式，通过AI加速新产品 ...

《BMJ 循证医学》主编 Juan Franco 表示："BMJ集团拥有深厚的历史积淀，始终以严谨的学术态度为基 石，推动全球医学科学的进步与发展。在这一进程中，将中国传统医学纳入循证医学框架，对全球医学 领域的突破至关重要。本次会议的举办，正是希望汇聚全球顶尖医学智慧，破解传统医学在证据体系构 建中的核心困境，推动中西医实现更深层次的融合与协同发展。" （原标题：《BMJ循证医学》圆桌会召开，顶尖专家共探中西医整合发展之道） 21世纪经济报道记者 闫硕 北京报道 2025年8月22日，由BMJ集团主办，北京中医药大学协办，扬子江药业公益支持的《BMJ 循证医学》圆 桌会在北京成功举办。本次圆桌会聚焦 "构建传统医学高质量证据框架、创新中西医协同整合机制、中 医临床干预的策略实践" 三大主题，旨在推动传统医学循证研究标准化发展，探索中西医协同整合创新 医疗模式，更通过跨学科、跨国界深度碰撞，为中医药文化创新与传承搭建国际交流平台，为全球医学 研究范式革新注入强劲动能。 《 BMJ 循证医学》圆桌会圆满举办 活动汇聚国内外顶尖专家，中国工程院、北京中医药大学田金洲院士，北京中医药大学副校长刘存志教 授，北京中医 ...

Financial Performance - The company reported an impressive operating cash flow of 0.92 CNY per share, reflecting a year-on-year increase of 991.52% [2] - The net cash flow from operating activities increased by 993.71% due to optimized cash flow management and accelerated discounting of receivables [2][5] Sales and Marketing Strategy - The company has established a strong presence in both B2C and O2O channels, achieving rapid growth by collaborating with major platforms and expanding its online medical resources [3] - The O2O strategy focuses on differentiated operations based on consumer needs, enhancing exposure and conversion rates through targeted marketing [3] - The company’s pain relief patches have outperformed the industry growth rate due to their dual efficacy in pain relief and anti-inflammation [4] Research and Development - The company is concentrating its R&D efforts on key therapeutic areas such as external pain relief, respiratory, and neurological treatments, with a focus on unmet clinical needs [4][6] - The new drug "Xiaoer Relixin Granules" has received clinical trial approval, enhancing the pediatric product pipeline [5] - R&D investment reached 48.65 million CNY in the first half of the year, a 3.31% increase year-on-year, with a R&D expense ratio of 5.6%, below the industry average [6] Market Position and Competitive Advantage - The company has established itself as a leading brand in the Tibetan medicine market, particularly in external pain relief [6] - The competitive landscape has intensified due to increased demand for topical anti-inflammatory products, but the company maintains a unique advantage with its multi-target Tibetan medicine formulations [4] - The company’s strategic focus on brand recognition and product differentiation supports its market leadership [6] Future Outlook - The company plans to enhance its cash flow management through improved receivables management and expanded financing channels to support business growth and R&D investments [5] - The ongoing construction of the pharmaceutical industrial base is on track, with production licenses being obtained for various formulations [4]

标准实施后，将从多维度促进鲜药在医疗机构中的规范应用，可进一步提升医疗机构中医药服务能力， 为市民打造更多元化的中医药诊疗体验。同时，也为中医药标准化、国际化提供重要依据，此外，标准 还将发挥辐射作用，带动鲜药种植、加工、物流等全产业链"一体化"发展，为中医药全面高质量发展续 上强效"引擎"。 宝安中医院（集团）将紧抓此次标准发布与实施的机遇，进一步深化鲜药在临床诊疗中的特色应用，同 时积极探索相关高质量科研项目开展，推动鲜药形成产业化、规模化发展，力争让这一传统中医药瑰宝 焕发新活力。 鲜药是中医药传统用药的重要形式，其药效迅速、活性成分保留完整等独特优势，在临床诊疗中具有不 可替代的地位。尤其在岭南地区，"鲜药鲜用"的诊疗特色深受医患信赖。然而，长期以来，鲜药因易腐 坏、难贮存等问题，在采收、加工、贮藏及临床应用环节缺乏统一标准，严重制约了其临床推广与疗效 发挥。 而此次发布的《医疗机构鲜药管理规范》全面融合传统经验与现代技术，为医疗机构提供了兼具科学性 和实用性的可操作、可落地技术指南。值得一提的是，标准中对鲜药采收加工、贮藏保鲜、临床应用、 质量控制等全流程进行了系统且细致的规范，不仅解决了鲜药易腐、 ...

Core Insights - The 2025 Jiangsu International Service Trade Expo was held in Kuala Lumpur, Malaysia, from August 22 to 24, focusing on the theme of "Service Sharing, Trade Win-Win" with an exhibition area of approximately 2,500 square meters and participation from over 70 key enterprises and institutions in various sectors [1][2] Group 1: Event Overview - The expo featured six key project signings covering areas such as cross-border e-commerce, cultural services, tourism services, intangible cultural heritage, and intellectual property, aimed at enhancing cooperation between China and Malaysia [1][2] - The event included various promotional activities such as digital animation exhibitions, intangible cultural heritage performances, and interviews, attracting numerous professional buyers and local visitors [3] Group 2: Economic and Strategic Context - Jiangsu's Deputy Director of Commerce highlighted the significance of the expo in the context of the 15th anniversary of the China-ASEAN Free Trade Area and recent high-level visits between China and Malaysia, emphasizing the importance of practical cooperation [2] - The expo is seen as a practical measure to implement the joint statement between China and Malaysia, contributing to the growth potential in service trade and investment cooperation [2] Group 3: Company Participation and Opportunities - Jiangsu Zhuoyi Cultural Development Co., Ltd. showcased over a hundred exquisite Yixing Zisha artworks and highlighted its digital copyright innovation platform, indicating strong interest from Southeast Asian clients during the expo [3] - The event provided a favorable environment for companies to explore integrated models of e-commerce, copyright, auction, and trading, leveraging Malaysia's position as a cultural hub and technology investment hotspot in ASEAN [3]

Core Viewpoint - The integration of modern medical technology with traditional Chinese medicine (TCM) enhances diagnostic accuracy and treatment options, emphasizing that modern techniques should complement, not replace, the holistic approach of TCM [1][6]. Group 1: Modern Technology in TCM - Modern medical examinations like CT and B-ultrasound are increasingly utilized in TCM to provide detailed insights into patients' conditions, allowing for more precise diagnoses and treatment plans [2][3]. - The concept of "five diagnoses" in TCM has evolved to include modern diagnostic tools, which help overcome the subjective limitations of traditional methods [2][3]. - The use of advanced imaging techniques, such as CTA, aids in assessing conditions like atherosclerosis, enabling tailored treatment strategies that may combine both TCM and modern interventions [3][4]. Group 2: Enhanced Treatment Options - The combination of TCM principles with modern techniques, such as visualized acupuncture, improves treatment precision and safety, making advanced therapies accessible to more patients [4][5]. - Real-time monitoring during procedures, like the use of ultrasound in needle-knife therapy, enhances the safety and effectiveness of treatments for conditions such as cervical spondylosis [5][6]. - The integration of modern technology into TCM practices is seen as a way to meet the growing demand for healthcare services while maintaining the essence of traditional practices [6][7]. Group 3: Policy and Future Directions - Recent government policies emphasize the importance of integrating modern science with TCM to foster innovation and improve healthcare quality [7]. - Continuous exploration of new treatment methods and understanding the mechanisms of TCM through modern scientific research is a key focus for the future development of the industry [7].

Core Viewpoint - The integration of modern medical technology and traditional Chinese medicine (TCM) enhances diagnostic accuracy and treatment options for patients, emphasizing that modern techniques should complement, not replace, the holistic approach of TCM [1][6]. Group 1: Modern Technology in TCM - Modern medical examinations like CT and B-ultrasound are increasingly utilized in TCM to provide detailed insights into patients' conditions, allowing for more precise diagnoses and treatment plans [2][3]. - The concept of "five diagnoses" in TCM has evolved to include modern diagnostic tools, which help overcome the subjective limitations of traditional methods [2][3]. - The use of visualized techniques, such as ultrasound-guided procedures, improves the safety and effectiveness of TCM treatments, allowing for real-time monitoring during interventions [4][5]. Group 2: Case Studies and Applications - A case study highlighted the importance of CT scans in diagnosing early-stage lung cancer, demonstrating how modern technology can lead to timely interventions that traditional methods alone might miss [2]. - Another example involved the use of ultrasound in treating cervical spondylosis, showcasing how modern techniques can enhance the precision of TCM treatments [5]. - The integration of modern diagnostic tools has proven beneficial in various conditions, such as arterial occlusion and gastric ulcers, where traditional methods were supplemented with advanced imaging for accurate diagnosis [3][4]. Group 3: Policy and Future Directions - Recent policies in China emphasize the importance of integrating modern science with TCM to enhance its development and innovation, aiming for high-quality growth in the sector [7]. - The ongoing exploration of new treatment methods and the application of modern scientific research to understand TCM's mechanisms are seen as vital for the future of the industry [7].

Core Points - The 6th China (Gansu) Traditional Chinese Medicine Industry Expo opened on August 24 in Longxi County, Gansu Province, focusing on the inheritance, innovation, and open sharing of traditional Chinese medicine [1] - Over 1,000 participants, including experts and representatives from the traditional Chinese medicine sector, as well as foreign guests from countries like South Korea and Thailand, attended the event [1] - Gansu is a major production area for traditional Chinese medicinal materials, with a planned planting area of 5.5 million mu by 2025 and 3,626 types of medicinal resources, including 276 of the 363 key varieties in the country [1] Industry Developments - Gansu's international cooperation in traditional Chinese medicine is deepening, with over 1,500 registered traditional Chinese medicine products overseas and exports to 15 countries and regions [1] - The establishment of 16 Qihuang Traditional Chinese Medicine Centers or Colleges in 12 countries, along with the unveiling of the "Dunhuang Medical Discipline" in Thailand last year, highlights Gansu's commitment to international collaboration [1] - Thailand's Public Health Ministry emphasizes the development of traditional medicine, implementing safety regulations, medical standards, and establishing TCM courses and clinics in public and private hospitals [1]

Core Viewpoint - The article highlights the significant growth and development of Traditional Chinese Medicine (TCM) services in China, emphasizing the establishment of a comprehensive TCM service system that enhances accessibility and quality of care for the population [1][2]. Group 1: TCM Service Accessibility - By the end of 2024, the total number of TCM consultations in China is projected to reach 1.66 billion, supported by an efficient healthcare service system [1]. - Approximately 42,000 TCM clinics are expected to be established, covering over 96% of community health service centers and township hospitals [2]. - More than 99% of community health service centers and township hospitals will provide TCM services, with about 91% of secondary and higher public hospitals having TCM clinical departments [2]. Group 2: Quality and Resource Expansion - The establishment of TCM national regional medical centers aims to expand high-quality TCM resources and ensure equitable distribution, with over 240 key specialties developed in under-resourced areas [4]. - More than 1,200 new medical technologies have been introduced, enhancing the diagnostic and treatment capabilities for complex and severe cases [4]. - New types of medical alliances are being formed to promote TCM specialties and improve collaboration between TCM and Western medicine [4]. Group 3: Enhancing TCM Service Capabilities - A total of 1,158 national TCM specialty departments have been selected to improve clinical efficacy and enhance specialty diagnostic capabilities [5]. - The usage rates of traditional Chinese medicine in various patient care scenarios have increased, with the use of Chinese herbal medicine reaching 76.29% and non-drug therapies at 88.33% [6]. - The focus on pediatric, geriatric, and rehabilitation services is being strengthened, with initiatives targeting specific health issues in children and adolescents [6].

Core Viewpoint - The company reported a total revenue of 5.379 billion and a net profit attributable to shareholders of 1.442 billion for the first half of 2025, amidst challenges in the pharmaceutical industry due to policy adjustments and market contraction [1] Group 1: Financial Performance - The company achieved total revenue of 5.379 billion and net profit of 1.442 billion in the first half of 2025 [1] - The second quarter of 2025 presented a complex operating environment due to dual challenges from healthcare policy adjustments and a shrinking consumer market [1] Group 2: Strategic Initiatives - To address market changes, the company focused on its core business and implemented effective measures to ensure stable operations [1] - The company strategically increased sales expenses to maintain steady sales revenue for its product series, enhancing market penetration and core product market share [1] Group 3: Market Expansion - The company invested in a northern headquarters in Beijing by the end of 2024, which is now in the initial operational phase, aimed at breaking through market bottlenecks and enhancing brand influence [2] - Although the increase in management expenses may weaken short-term profit performance, it is expected to provide significant long-term strategic value [2] Group 4: Cost Management - The price of natural bezoar, a key raw material, has decreased from 1.65 million per kilogram to 1.5 million per kilogram, which is anticipated to relieve cost pressures on the company's core products [2] Group 5: Research and Development - The company advanced its R&D pipeline with two new drug projects and 18 ongoing research projects, including clinical approvals for several products [3] - The establishment of the "Fujian Provincial Academician Expert Workstation" and participation in government-driven industrial funds are expected to enhance the company's position in the traditional Chinese medicine sector [3] Group 6: Operational Efficiency - The company has implemented a systematic response plan to address income and profit pressures, including establishing a raw material price monitoring mechanism and optimizing strategic reserves [4] - Continuous tracking of industry policies and market dynamics, along with differentiated marketing strategies, aims to convert external challenges into competitive advantages [4]